Hong Kong based company LUQA and Catalan company Laboratorios SALVAT, S.A. have reached an agreement for the commercialization of pharmaceutical product Cetraxal Plus in Taiwan. LUQA is a specialty company devoted to the commercialization of pharmaceutical products in the East Asia emerging markets, whereas Laboratorios SALVAT, S.A. is a renowned company that has been commercializing their products, like Cetraxal Plus, for more than 20 years on international markets.
[caption id="" align="aligncenter" width="331" caption="Cetraxal Plus (Image from LUQA website)"]
[/caption]
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.